Polypharmacy in diabetes prescribing
This interactive session will aim to illustrate the importance of deprescribing in polypharmacy and individualisation of diabetes therapy optimisation. We will bring in real-life case studies to highlight the practicalities and application of guideline recommendations taking into account patient factors and co-morbidities.
Learning Outcomes: - Understand the impact of deprescribing in polypharmacy in people with diabetes. - Gain an awareness of up-to-date
- - Understand the impact of deprescribing in polypharmacy in people with diabetes. - Gain an awareness of up-to-date diabetes medicines optimisation guideline recommendations, in particular in those with type 2 diabetes and frailty or at high cardiovascular risk. - Able to apply guideline recommendations in individuals with multi-morbid diabetes.